Lv1
78 积分 2022-06-14 加入
Incidence of Inflammatory Bowel Disease in Urban China: A Nationwide Population-based Study
7天前
已完结
[Recommendations for diagnosis and treatment of ankylosing spondylitis]
10天前
已完结
Targeting TYK2 for Fighting Diseases: Recent Advance of TYK2 Inhibitors
22天前
已完结
Ulcerative colitis
30天前
已完结
[2024 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis]
1个月前
已完结
Rethinking bronchiectasis as an inflammatory disease
2个月前
已完结
The role of PI3Kγ in the immune system: new insights and translational implications
3个月前
已完结
CLINICAL EFFECTS OF TRAMIPROSATE IN APOE4/4 HOMOZYGOUS PATIENTS WITH MILD ALZHEIMER’S DISEASE SUGGEST DISEASE MODIFICATION POTENTIAL
8个月前
已完结
ActRIIB small molecule inhibitor 2-67 ameliorates muscle atrophy in cancer cachexia by inhibiting the myostatin/Smad pathway
9个月前
已关闭
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6+T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation
1年前
已完结
皖公网安备34019202002308
